One of the most interesting findings of this study was that the technology provided opportunities for clinicians and patients to use the technology adaptively and differently, allowing new modes of consulting to evolve (eg, patient-initiated contacts direct to the clinician via Skype messaging, which appeared to help supported self-adjustment of insulin dosage in diabetes). The gene discussed is INS; the disease is diabetes mellitus.